title: Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases.
abstract: Ly-GDI (lymphoid-specific guanosine diphosphate (GDP) dissociation inhibitor), also called D4-GDI, is preferentially expressed in hematopoietic tissues including bone marrow, thymus, spleen and lymph nodes. It binds to the small guanosine triphosphate (GTP)-binding protein Rho and inhibits GDP dissociation from Rho proteins. To explore the function of Ly-GDI in lymphocytes, we have generated Ly-GDI-deficient mice by gene targeting. These mice showed no striking abnormalities of lymphoid development or thymocyte selection. The mice also exhibited, for the most part, normal immune responses including lymphocyte proliferation, IL-2 production, cytotoxic T lymphocyte activity, antibody production, antigen processing and presentation, immune cell aggregation and migration, and protection against an intracellular protozoan. However, Ly-GDI-deficient mice exhibited deregulated T and B cell interactions after in vitro cultivation of mixed lymphocyte populations in concanavalin A (Con A) leading to overexpansion of B lymphocytes. Further studies revealed that Ly-GDI deficiency decreased IL-2 withdrawal apoptosis of lymph node cells while dexamethasone- and T cell receptor-induced apoptosis remained intact. These data implicate the regulation of the Rho GTPase by Ly-GDI in lymphocyte survival and responsiveness, but suggest that these functions may be partially complemented by other Rho regulatory proteins when the Ly-GDI protein is deficient.
authors.affiliation: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, U.S.A.
authors.forename: L
authors.initials: L
authors.lastname: Yin
authors.forename: P
authors.initials: P
authors.lastname: Schwartzberg
authors.forename: T M
authors.initials: TM
authors.lastname: Scharton-Kersten
authors.forename: L
authors.initials: L
authors.lastname: Staudt
authors.forename: M
authors.initials: M
authors.lastname: Lenardo
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D017209:Apoptosis; D002470:Cell Survival; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D019204:GTP-Binding Proteins / Q000378:metabolism*; D020730:Guanine Nucleotide Dissociation Inhibitors; D006182:H-Y Antigen / Q000235:genetics; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D015778:Minor Histocompatibility Antigens; D011506:Proteins / Q000502:physiology*; D014124:Toxoplasmosis, Animal / Q000276:immunology; D020741:rho GTP-Binding Proteins; D062949:rho Guanine Nucleotide Dissociation Inhibitor beta; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors
chemical_list: C569659:Arhgdib protein, mouse; D020730:Guanine Nucleotide Dissociation Inhibitors; D006182:H-Y Antigen; D015778:Minor Histocompatibility Antigens; D011506:Proteins; D062949:rho Guanine Nucleotide Dissociation Inhibitor beta; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors; D003208:Concanavalin A; D019204:GTP-Binding Proteins; D020741:rho GTP-Binding Proteins